NCT03180736 2025-12-19EMN14European Myeloma Network B.V.Phase 3 Completed304 enrolled 19 charts 1 FDA
NCT06455748 2024-06-12Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm StudyFirst Affiliated Hospital of Wenzhou Medical UniversityPhase NA Recruiting20 enrolled